Bretylium Tosylate In Dextrose 5%

   
Google
 
Web NewDrugInformation.com

Bretylium Tosylate In Dextrose 5%


Drug - Bretylium Tosylate In Dextrose 5%
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bretylium Tosylate
Multiple ingredients are in alphabetical order.

Strength - 800MG/100ML
The potency of the active ingredient(s), Bretylium Tosylate. May repeat for multiple part products.

Applicant - ABBOTT
The firm name holding legal responsibility for Bretylium Tosylate In Dextrose 5%. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019005
The FDA assigned number to Bretylium Tosylate In Dextrose 5%. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Bretylium Tosylate In Dextrose 5%. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 29, 1986
The date Bretylium Tosylate In Dextrose 5% was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Bretylium Tosylate In Dextrose 5%. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Bretylium Tosylate In Dextrose 5% is in. Format is RX, OTC, DISCN.

Applicant Full Name - Abbott Laboratories Pharmaceutical Products Div
The full name of the firm holding legal responsibility for the new application of Bretylium Tosylate In Dextrose 5%.

Bretylium Tosylate In Dextrose 5%